These compounds can inhibit NF-κB and its downstream inflammatory factors, thereby suppressing the proliferation, angiogenesis, and invasion of liver cancer cells while promoting apoptosis [19,20,21]. The gene discussed is NFKB1; the disease is liver cancer.